- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06368011
The Impact of Acceptance and Commitment Therapy on Stigmatization
The Effect of Acceptance and Commitment Therapy-Based Psychoeducation on Stigmatization Levels of Schizophrenia Patient Relatives
The goal of study is to determine the effect of acceptance and commitment therapy-based psychoeducation on the level of stigmatization applied to relatives of schizophrenia patients.
Type of study: This study was planned as a pretest-posttest quasi-experimental design with an observation and control group.
Participants: The population of the study consisted of the relatives of schizophrenia patients who were registered and actively attending the Community Mental Health Center in a state hospital in Ankara.
Intervention: Before the psychoeducation process started, personal information form and scales were applied to the relatives of the patients in the experimental and control groups. An ACT-based psychoeducation program consisting of 8 sessions was applied to the experimental group. each session lasted approximately 90 minutes. The control group did not receive any intervention. After the psychoeducation, the scales were reapplied to the experimental and control groups. In addition, the experimental group was asked to fill out the psychoeducation evaluation form. The scales were reapplied to the experimental group after the 1-month follow-up study and evaluated.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim The aim of this study is to determine the effect of Acceptance and Commitment Therapy (ACT)-based psychoeducation on the level of stigmatization of mental illness in the relatives of individuals diagnosed with schizophrenia.
Study Desing The design of the study is an experimental research with pretest-posttest, follow-up measurement experiment and control group.
Hypotheses The reserach hypotheses are as follows; H0: acceptance and commitment therapy has no effect on the level of stigmatization.
H1: Psychoeducation based on acceptance and commitment therapy is effective in reducing the stigmatization levels of relatives of schizophrenia patients.
Variables of the study The study's dependent variable is stigma , and the independent variable is ACT based psychoeducation.
Settings The research was conducted between April 2023 and July 2023 with the relatives of patients diagnosed with schizophrenia who were followed up at the Ministry of Health Dr. Nafiz Körez Sincan State Hospital Community Mental Health Center.
Participants The sample of this study consisted of relatives of patients diagnosed with schizophrenia who were followed up in Dr. Nafiz Körez Sincan State Hospital Community Mental Health Center. After determining the sufficient number of relatives for the sample, randomization was performed. The relatives of the patients included in the study were randomly assigned to the experimental and control groups. There was no loss of sample in both groups during the psychoeducation period and the study was completed with 36 relatives of the patients.
Information Form: the researcher prepared this form, consisting of questions about the sociodemographic characteristics of relatives of schizophrenia patients, stigmatization scale and stigma scale for relatives of schizophrenia patients.
Stigma Scale For Relatives of Schizophrenia Patients.The scale developed by Yıldırım et al. was prepared as a 3-point Likert-type scale. Yes: 3, Sometimes: 2, No: 1 and scored as Yes: 3, Sometimes: 2, No: 1. The minimum score that can be obtained from the scale is 17 and the maximum score is 51. There are no reverse scored items. The scale is interpreted on both the total score and the subscale scores, and the higher the score obtained from the scale and subscales, the more stigmatization is expressed. The stigmatization scale for relatives of schizophrenia patients consists of 17 questions and 5 subscales. Social isolation and inadequacy sub-dimension 1, 2, 3, 4, 9, 15 avoidance and deterioration in interpersonal relationships sub-dimension: 5, 6, 7 social negative discrimination sub-dimension: 8, 10, 11 concealment and shame subscale: 12, 13, 14 negative internalization subscale: 16, 17 items. In the reliability study, the Cronbach's Alpha coefficient of the scale was found to be 0.90. The Cronbach's Alpha internal consistency coefficients of the Stigma Scale for Relatives of Schizophrenia Patients were calculated as 0.87; 0.80; 0.76; 0.71; 0.69 for the sub-dimensions of social isolation and inadequacy, avoidance and deterioration in interpersonal relationships, social negative discrimination, concealment and shame, and negative internalization, respectively. In the present study, the reliability of the CCPBS scale was found to be high as Cronbach's Alpha=0.839.
Stigmatization Scale: The scale is a 5-point Likert-type. It is answered and scored as Strongly Disagree: 1, Disagree: 2, Partially Agree: 3, Agree: 4, Strongly Agree: 5. The score that can be obtained from the scale is between 22-110, and it can be said that individuals who score below 55 points have a low stigmatization tendency, while individuals who score above 55 points have a high stigmatization tendency. The Stigmatization Scale consists of 22 items and 4 dimensions and there are no reverse scored items. Discrimination and exclusion sub-dimension 10,17,18,19,20,21 labeling sub-dimension 3,4,5,7,8,9 psychological health sub-dimension 11,12,13,15,16, prejudice sub-dimension 1,2,6,14,22. In the reliability study, Cronbach's Alpha coefficient of the scale was found to be 0.84. Cronbach's Alpha internal consistency coefficients of the Stigma Scale were found to be 0.77, 0.68, 0.66, 0.54 for discrimination and exclusion, labeling, psychological health, and prejudice sub-dimensions, respectively. In this study, the reliability of the Stigmatization scale was found to be high as Cronbach's Alpha=0.827.
Data Collection: Before the psychoeducation process started, personal information form and scales were applied to the relatives of the patients in the experimental and control groups. ACT-based psychoeducation program was applied to the experimental group. The psychoeducation program was carried out in 8 sessions, each session lasting approximately 90 minutes. The control group did not receive any intervention. After the psychoeducation program given to the experimental group, the scales were reapplied to the experimental and control groups. In addition, the experimental group was asked to fill out the psychoeducation evaluation form. After 1 month of follow-up study, the scales were applied to the experimental group again and evaluated.
Psychoeducation was provided to two separate groups of 8-10 individuals in the experimental group in 8 sessions lasting 90 minutes. The group sessions were conducted once a week at the TRSM under the leadership of the researcher. In total, the psychoeducation lasted 10 weeks including make-up sessions. The sessions were held in the multi-purpose training hall of the TRSM, which had appropriate conditions for psychoeducation (a table and enough chairs, blackboard, computer, overhead projector).
Data Analysis The data obtained in the study were evaluated in computer environment through SPSS 22.0 statistical program. Frequency and percentage analyses were used to determine the descriptive characteristics of the employees participating in the study, and mean and standard deviation statistics were used to examine the scale. Kurtosis and Skewness values were analyzed to determine whether the research variables were normally distributed. It was determined that the variables were normally distributed. Parametric methods were used to analyze the data.Differences between the rates of categorical variables in independent groups were analyzed with Chi-Square and Fisher exact tests. Independent groups t-test was used to compare quantitative continuous data between two independent groups. Repeated measures anova test and complementary bonferroni test were used to compare within-group measurements.
Funding No expenditure will be made on any item other than the consumables of the existing forms for the research. the researcher will cover stationery and consumables.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hatay, Turkey
- Hatay Mustafa Kemal Üniversitesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being a relative of a patient diagnosed with schizophrenia according to DSM-V diagnostic criteria
- Living with the patient (family member living with the patient for at least 35 hours or more per week)
- Volunteering to participate in the research,
- To be able to read and write
- 18 years of age or older
Exclusion Criteria:
- Not having attended any session of the eight-session training program and not having attended the make-up session
- Not having participated in any of the pre-test, post-test and follow-up test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental group:relatives of schizophrenia patients
The population of the study consisted of the relatives of schizophrenia patients who were registered and actively attending the Ministry of Health Dr. Nafiz Körez Sincan State Hospital Community Mental Health Center.The sample size of the study was calculated at 95% confidence level according to the independent t test using 'G.
Power-3.1.9.7' before the study was started.As a result of the analysis, the minimum sample size was calculated as 32, with 16 in the experimental group and 16 in the control group.
|
Psychoeducation was delivered in 8 sessions lasting 90 minutes to two separate groups of 8-10 individuals in the experimental group.Group sessions were conducted once a week at the community mental health center under the leadership of the researcher.In total, the psychoeducation lasted 10 weeks, including make-up sessions.
|
|
No Intervention: control group:relatives of schizophrenia patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stigma Scale for Relatives of Patients with Schizophrenia
Time Frame: Pre-test (before the intervention), post test (ten weeks after the intervention) and one month after follow up
|
It is a 3-point Likert-type scale.
Yes: 3, Sometimes: 2, No: 1 and is scored as followsThe lowest score that can be obtained from the scale is 17 and the highest score is 51.
|
Pre-test (before the intervention), post test (ten weeks after the intervention) and one month after follow up
|
|
Stigma Scale for Relatives of Patients with Schizophrenia
Time Frame: post test (ten weeks after the intervention)
|
It is a 3-point Likert-type scale.
Yes: 3, Sometimes: 2, No: 1 and is scored as followsThe lowest score that can be obtained from the scale is 17 and the highest score is 51.
|
post test (ten weeks after the intervention)
|
|
Stigma Scale for Relatives of Patients with Schizophrenia
Time Frame: one month after follow up
|
It is a 3-point Likert-type scale.
Yes: 3, Sometimes: 2, No: 1 and is scored as followsThe lowest score that can be obtained from the scale is 17 and the highest score is 51.
|
one month after follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stigmatization Scale
Time Frame: Pre-test (before the intervention), post test (ten weeks after the intervention) and one month after follow up
|
It is a 5-point Likert-type scale.
It is answered and scored as Strongly Disagree: 1, Disagree: 2, Partially Agree: 3, Agree: 4, Strongly Agree: 5.
The score that can be obtained from the scale is between 22-110, and it can be said that individuals who score below 55 points have a low tendency to stigmatize, while individuals who score above 55 points have a high tendency to stigmatize.
|
Pre-test (before the intervention), post test (ten weeks after the intervention) and one month after follow up
|
|
Stigmatization Scale
Time Frame: post test (ten weeks after the intervention)
|
It is a 5-point Likert-type scale.
It is answered and scored as Strongly Disagree: 1, Disagree: 2, Partially Agree: 3, Agree: 4, Strongly Agree: 5.
The score that can be obtained from the scale is between 22-110, and it can be said that individuals who score below 55 points have a low tendency to stigmatize, while individuals who score above 55 points have a high tendency to stigmatize.
|
post test (ten weeks after the intervention)
|
|
Stigmatization Scale
Time Frame: one month after follow up
|
It is a 5-point Likert-type scale.
It is answered and scored as Strongly Disagree: 1, Disagree: 2, Partially Agree: 3, Agree: 4, Strongly Agree: 5.
The score that can be obtained from the scale is between 22-110, and it can be said that individuals who score below 55 points have a low tendency to stigmatize, while individuals who score above 55 points have a high tendency to stigmatize.
|
one month after follow up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MustafaKU-CINCINOGLU-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stigmatization
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)Completed
-
Suez Canal UniversityCompletedMedical Education | StigmatizationEgypt
-
Hong Kong Metropolitan UniversityCompletedStigmatization | Sex Work | Transgenderism | HomosexualityHong Kong
-
George Washington UniversityCompletedDepression | Psychosis | StigmatizationNepal
-
Sakarya UniversityCompletedInflammation | Sexuality | StigmatizationTurkey
-
Semmelweis UniversityCompletedMental Illness | StigmatizationHungary, Croatia, Albania, Austria, Azerbaijan, Belarus, Bulgaria, Cyprus, Czechia, Denmark, Estonia, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Malta, Montenegro, Netherlands, Portugal, Russian Federation, Serbia, Slov... and more
-
Yale UniversityCompleted
-
Fakeeh College for Medical SciencesCompleted
-
Lakehead UniversityIllinois Institute of Technology, Chicago, USACompletedMental Health Issue | Stigmatization | DisclosureCanada
-
University of PennsylvaniaWeight Watchers InternationalCompletedObesity | Weight Loss | StigmatizationUnited States
Clinical Trials on acceptance and commitment therapy
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
Universidade Federal do ParanáActive, not recruitingObsessive-Compulsive DisorderBrazil
-
University of CoimbraUnknown
-
Ataturk UniversityNot yet recruitingChronic Mental DisordersTurkey
-
Universiti Sains MalaysiaRecruitingBreast Cancer FemaleMalaysia
-
University of CyprusNot yet recruitingDepression | Anxiety Disorders | Post Traumatic Stress Disorder
-
University of TromsoThe Royal Norwegian Ministry of HealthCompleted
-
University of NottinghamNottinghamshire Healthcare NHS Foundation Trust; Derbyshire Healthcare NHS...Completed
-
University of Alabama at BirminghamWithdrawn
-
Nova Scotia Health AuthorityCompleted